Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Beijing Health (Holdings) Limited ( (HK:2389) ) has issued an update.
Beijing Health (Holdings) Limited has called its annual general meeting for 2 June 2026 in Hong Kong, where shareholders will review and adopt the 2025 audited financial statements and the reports of the board and auditors. The agenda also includes re-election of executive directors Gu Shan Chao and Wang Zheng Chun and independent non-executive director Zhang Yun Zhou, authorization for the board or its remuneration committee to set directors’ pay, and re-appointment of Ernst & Young as auditor with authority for the board to fix audit fees.
Shareholders will further be asked to grant the board a general mandate to repurchase up to 10% of the company’s issued shares, excluding any treasury shares, during a defined mandate period. This buyback authority, if approved, would enhance the board’s capital-management flexibility and could influence future capital structure and shareholder returns, underscoring ongoing efforts to align governance and financial policies with investor expectations.
More about Beijing Health (Holdings) Limited
Beijing Health (Holdings) Limited is a Cayman Islands-incorporated company listed in Hong Kong under stock code 2389. The group operates within the healthcare-related sector, though the notice focuses on corporate governance matters rather than detailed operational activities or specific product and service lines.
Average Trading Volume: 1,413,207
Technical Sentiment Signal: Sell
Current Market Cap: HK$393.8M
See more insights into 2389 stock on TipRanks’ Stock Analysis page.